The incidence of diabetes or pre-diabetes was found to double for men compared to women, according to figures released by Vhi Healthcare to mark 2012 Type 2 Diabetes Day.

Merck Serono, a division of Merck, has announced that Rebif (interferon beta-1a) is now available in Ireland to treat people who have experienced clinically isolated syndrome (CIS), a potential early sign of multiple sclerosis (MS).

Roche has announced results from CLEOPATRA, the first randomised phase III study of the investigational HER2-targeted medicine pertuzumab.

Pfizer has announced it has entered into a second supply agreement which will broaden and extend the duration of the company’s commitment to help protect millions of infants and young children in the developing world from pneumococcal disease – the leading cause of vaccine-preventable death in young children.